Pharma Two B

Pharma Two B is a late-stage pharmaceutical company developing innovative combination products of previously approved drugs to treat early Parkinson's disease and liver diseases.

placeRehovot, Central District, Israel calendar_todayFounded 2007 groups12 employees language pharma2b.com

Innovation

7 patent families (4 granted) — focus: Human necessities; filing pace slowing. Cited 253 times.

YearFilings
20122
20133
20143
20153
20163
20173
20183
20191
20202
20211
20222
20231

Investor mix

6 investors on record; lead investors include Israel Biotech Fund, JVC Investment Partners, JK&B Capital, Generali.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%
Coming soon